Cencora, Inc. (COR)
NYSE · Common stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries
As of Oct 21, 2:17 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow COR in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on COR and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
COR at a glance
Key statistics
$65.51B
Market capitalization
- Previous close
- $343.27
- Open
- $341.06
- Day range
- $338.38 – $344.07
- Volume
- 565.7K
- Average volume (30 sessions)
- 1.23M
- Shares outstanding
- 190.83M
- Price / earnings
- 25.0
- Earnings per share
- $13.75
- Price / book
- 21.5
- Price / sales
- 0.2
- Dividend yield
- 0.71%
- Beta (1 year, vs SPY)
- -0.13
Where the price sits in its year
52-week range
72% of the range
- Below the 52-week high
- -9.9%
- Above the 52-week low
- +39.0%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $320.51+7.1%
- 50-day average
- $321.00+6.9%
- 200-day average
- $317.52+8.1%
In the band above 70 that convention calls overbought. Strong trends can stay there for weeks.
+4.0%
1 week
+8.5%
1 month
+14.2%
3 months
+1.6%
Year to date
+5.7%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with COR
COR on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on COR.
See the plans →
Every planScreen names like COR
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on COR
Put COR on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on COR
See whether there is an open premium alert on COR, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
COR headlines
- Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss
Benzinga · Feb 4, 2026
- Cencora Strikes $5 Billion OneOncology Deal, Pauses Stock Buyback
Benzinga · Dec 15, 2025
- Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook
Benzinga · Aug 6, 2025
- Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel
GlobeNewswire Inc. · Jul 28, 2025
- Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings
Benzinga · Nov 6, 2024
- Opioid Settlement: Drug Distributors McKesson, Cencora, Cardinal Health To Pay $300M To Health Insurers
Benzinga · Sep 3, 2024
- Unveiling 4 Analyst Insights On Cencora
Benzinga · May 2, 2024
SEC Form 4, most recent first
Insider filings
Krikorian Lazarus
−986
SVP & Chief Accounting Officer · Open-market sale
$298.94K · Oct 1, 2026
SANCHEZ ROBERT E
+275
Director · Grant or award
· Oct 1, 2026
GREENBERG LON R
−1.3K
Director · Open-market sale
$411.26K · Sep 16, 2026
Krikorian Lazarus
−985
SVP & Chief Accounting Officer · Open-market sale
$321.08K · Sep 1, 2026
Campbell Elizabeth S
−11.3K
Executive Vice President · Open-market sale
$3.66M · Aug 24, 2026
Cooper Ellen
+97
Director · Grant or award
$30.20K · Jul 31, 2026
NALLY DENNIS M
+113
Director · Grant or award
$35.18K · Jul 31, 2026
Tyler Lauren M
+97
Director · Grant or award
$30.20K · Jul 31, 2026
About Cencora, Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
- Exchange
- NYSE
- Security
- Common stock
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Headquarters
- Conshohocken, PA
- Employees
- 51,000
- Listed since
- Apr 4, 1995
- Website
- cencora.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.